Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

A closer look at the subordinate population within the visible burrow system.

Melhorn SJ, Elfers CT, Scott KA, Sakai RR.

Physiol Behav. 2017 Sep 1;178:110-116. doi: 10.1016/j.physbeh.2017.01.039. Epub 2017 Jan 24.

PMID:
28130085
2.

Posttraumatic stress disorder: A metabolic disorder in disguise?

Michopoulos V, Vester A, Neigh G.

Exp Neurol. 2016 Oct;284(Pt B):220-229. doi: 10.1016/j.expneurol.2016.05.038. Epub 2016 May 28. Review.

PMID:
27246996
3.

Modulation of Fear Extinction by Stress, Stress Hormones and Estradiol: A Review.

Stockhorst U, Antov MI.

Front Behav Neurosci. 2016 Jan 26;9:359. doi: 10.3389/fnbeh.2015.00359. eCollection 2015. Review.

4.

Pancreatic polypeptide and its central Y4 receptors are essential for cued fear extinction and permanent suppression of fear.

Verma D, Hörmer B, Bellmann-Sickert K, Thieme V, Beck-Sickinger AG, Herzog H, Sperk G, Tasan RO.

Br J Pharmacol. 2016 Jun;173(12):1925-38. doi: 10.1111/bph.13456. Epub 2016 May 19.

5.

Neuropeptide Y input to the rat basolateral amygdala complex and modulation by conditioned fear.

Leitermann RJ, Rostkowski AB, Urban JH.

J Comp Neurol. 2016 Aug 15;524(12):2418-39. doi: 10.1002/cne.23960. Epub 2016 Feb 2.

PMID:
26779765
6.

Structure and function of the amygdaloid NPY system: NPY Y2 receptors regulate excitatory and inhibitory synaptic transmission in the centromedial amygdala.

Wood J, Verma D, Lach G, Bonaventure P, Herzog H, Sperk G, Tasan RO.

Brain Struct Funct. 2016 Sep;221(7):3373-91. doi: 10.1007/s00429-015-1107-7. Epub 2015 Sep 13.

7.

Hunger Promotes Fear Extinction by Activation of an Amygdala Microcircuit.

Verma D, Wood J, Lach G, Herzog H, Sperk G, Tasan R.

Neuropsychopharmacology. 2016 Jan;41(2):431-9. doi: 10.1038/npp.2015.163. Epub 2015 Jun 11.

8.

A rodent model of traumatic stress induces lasting sleep and quantitative electroencephalographic disturbances.

Nedelcovych MT, Gould RW, Zhan X, Bubser M, Gong X, Grannan M, Thompson AT, Ivarsson M, Lindsley CW, Conn PJ, Jones CK.

ACS Chem Neurosci. 2015 Mar 18;6(3):485-93. doi: 10.1021/cn500342u. Epub 2015 Jan 28.

9.

Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders.

Singewald N, Schmuckermair C, Whittle N, Holmes A, Ressler KJ.

Pharmacol Ther. 2015 May;149:150-90. doi: 10.1016/j.pharmthera.2014.12.004. Epub 2014 Dec 27. Review.

10.

Targeting the Neuropeptide Y System in Stress-related Psychiatric Disorders.

Enman NM, Sabban EL, McGonigle P, Van Bockstaele EJ.

Neurobiol Stress. 2015 Jan 1;1:33-43.

11.

The central amygdala as an integrative hub for anxiety and alcohol use disorders.

Gilpin NW, Herman MA, Roberto M.

Biol Psychiatry. 2015 May 15;77(10):859-69. doi: 10.1016/j.biopsych.2014.09.008. Epub 2014 Sep 22. Review.

12.

Mechanisms to medicines: elucidating neural and molecular substrates of fear extinction to identify novel treatments for anxiety disorders.

Bukalo O, Pinard CR, Holmes A.

Br J Pharmacol. 2014 Oct;171(20):4690-718. doi: 10.1111/bph.12779. Epub 2014 Jul 23. Review.

13.

Cerebrospinal fluid neuropeptide Y in combat veterans with and without posttraumatic stress disorder.

Sah R, Ekhator NN, Jefferson-Wilson L, Horn PS, Geracioti TD Jr.

Psychoneuroendocrinology. 2014 Feb;40:277-83. doi: 10.1016/j.psyneuen.2013.10.017. Epub 2013 Nov 5.

14.

Can fear extinction be enhanced? A review of pharmacological and behavioral findings.

Fitzgerald PJ, Seemann JR, Maren S.

Brain Res Bull. 2014 Jun;105:46-60. doi: 10.1016/j.brainresbull.2013.12.007. Epub 2013 Dec 25. Review.

15.

Amnesia for early life stress does not preclude the adult development of posttraumatic stress disorder symptoms in rats.

Poulos AM, Reger M, Mehta N, Zhuravka I, Sterlace SS, Gannam C, Hovda DA, Giza CC, Fanselow MS.

Biol Psychiatry. 2014 Aug 15;76(4):306-14. doi: 10.1016/j.biopsych.2013.10.007. Epub 2013 Oct 12.

16.

Genetic approaches to understanding post-traumatic stress disorder.

Almli LM, Fani N, Smith AK, Ressler KJ.

Int J Neuropsychopharmacol. 2014 Feb;17(2):355-70. doi: 10.1017/S1461145713001090. Epub 2013 Oct 8. Review.

17.

Estrogen-related receptor β deficiency alters body composition and response to restraint stress.

Byerly MS, Swanson RD, Wong GW, Blackshaw S.

BMC Physiol. 2013 Sep 22;13:10. doi: 10.1186/1472-6793-13-10.

18.

Inhibitory networks of the amygdala for emotional memory.

Lee S, Kim SJ, Kwon OB, Lee JH, Kim JH.

Front Neural Circuits. 2013 Aug 1;7:129. doi: 10.3389/fncir.2013.00129. eCollection 2013. Review.

19.

Effects of stress on AMPA receptor distribution and function in the basolateral amygdala.

Hubert GW, Li C, Rainnie DG, Muly EC.

Brain Struct Funct. 2014 Jul;219(4):1169-79. doi: 10.1007/s00429-013-0557-z. Epub 2013 May 5.

20.

NPY Y1 receptors differentially modulate GABAA and NMDA receptors via divergent signal-transduction pathways to reduce excitability of amygdala neurons.

Molosh AI, Sajdyk TJ, Truitt WA, Zhu W, Oxford GS, Shekhar A.

Neuropsychopharmacology. 2013 Jun;38(7):1352-64. doi: 10.1038/npp.2013.33. Epub 2013 Jan 28.

Supplemental Content

Support Center